文献速递老年精神精神分裂症与精神病性障碍

精神分裂症遗传风险与阿尔茨海默病精神病性症状的负相关

Genetic risk for schizophrenia and psychosis in Alzheimer disease.
PubMed 文献 · Mol Psychiatry · 2017-05-02

该研究在发现队列2876例阿尔茨海默病(AD)患者(伴精神病性症状1761例、不伴1115例)中评估与精神分裂症及AD相关的单核苷酸多态性,并在2194例AD独立队列中验证。结果发现AD伴精神病性症状与一组新位点的多基因风险相关,且与精神分裂症多基因风险呈负相关。

要点

  • AD伴精神病性症状与一组新位点多基因风险正相关。
  • AD伴精神病性症状与精神分裂症多基因风险呈负相关。
  • 相关通路涉及内体运输、自噬和钙通道信号。

核心结论

  • AD伴精神病性症状与一组新位点的多基因风险相关,并与精神分裂症多基因风险呈负相关。

研究设计与样本

  • 发现队列纳入2876例AD患者(伴精神病性症状1761例、不伴1115例),使用定制基因分型芯片检测与AD伴精神病性症状及精神分裂症和AD风险相关的SNP。
  • 结果在2194例AD独立队列(伴精神病性症状734例、不伴1460例)中验证。

主要发现

  • AD伴精神病性症状与一组新位点的多基因风险相关。
  • AD伴精神病性症状与精神分裂症多基因风险呈负相关。
  • 精神分裂症SNP与AD伴精神病性症状关联涉及的生物学通路包括内体运输、自噬和钙通道信号。

临床怎么用

  • 可关注精神分裂症多基因风险较低是否与AD精神病性症状风险降低相关,以探索保护性机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD), affecting ~40 to 60% of individuals with AD (AD with psychosis (AD+P)). In comparison with AD subjects without psychosis, AD+P subjects have more rapid cognitive decline and poor outcomes. Prior studies have estimated the heritability of psychosis in AD at 61%, but the underlying genetic sources of this risk are not known. We evaluated a Discovery Cohort of 2876 AD subjects with (N=1761) or without psychosis (N=1115). All subjects were genotyped using a custom genotyping array designed to evaluate single-nucleotide polymorphisms (SNPs) with evidence of genetic association with AD+P and include SNPs affecting or putatively affecting risk for schizophrenia and AD. Results were replicated in an independent cohort of 2194 AD subjects with (N=734) or without psychosis (N=1460). We found that AD+P is associated with polygenic risk for a set of novel loci and inversely associated with polygenic risk for schizophrenia. Among the biologic pathways identified by the associations of schizophrenia SNPs with AD+P are endosomal trafficking, autophagy and calcium channel signaling. To the best of our knowledge, these findings provide the first clear demonstration that AD+P is associated with common genetic variation. In addition, they provide an unbiased link between polygenic risk for schizophrenia and a lower risk of psychosis in AD. This provides an opportunity to leverage progress made in identifying the biologic effects of schizophrenia alleles to identify novel mechanisms protecting against more rapid cognitive decline and psychosis risk in AD.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. DeMichele-Sweet MAA, Weamer EA, Klei L, et al. Genetic risk for schizophrenia and psychosis in Alzheimer disease. Mol Psychiatry. 2017. PMID: 28461698. doi:10.1038/mp.2017.81

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。